Atlas Trials

The Relationship Between CMV* Reactivation and Anti-cytokine Treatment in Critical COVID-19 Patients

Clinical trial NCT05419206 · COMPLETED

Trial details

NCT number
NCT05419206
Sponsor
Ramazan Gozukucuk
Status
COMPLETED
Study type
OBSERVATIONAL
COVID-19, Cytomegalovirus (CMV), Tocilizumab, Anakinra, Mortality
Start date
2020-03-15
Primary completion
2021-12-31
Enrollment
167

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.